PrEP, or pre-exposure prophylaxis, is a once-daily pill that can reduce your chance of getting HIV by more than 90%. According to the Centers for Disease Control and Prevention (CDC),…

A promising HIV vaccine candidate demonstrated its power by neutralizing HIV strains in mice, guinea pigs and monkeys, and is almost ready for human testing. The findings were published on June 4th…

An HIV-negative child received a liver transplant from its HIV-positive mother and now appears to have no evidence of HIV infection apart from a very weak antibody response. The case…

New results are raising hopes for easing one challenge of living with HIV: the need to take daily pills for life, both to ward off HIV/AIDS and to lower the…

More than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests.…

Results from a nationwide analysis on the impact of Truvada for pre-exposure prophylaxis (PrEP) showed that its use resulted in significant declines in new HIV infections in the US from 2012 to…

A smartphone app, developed at the University of Virginia School of Medicine to improve care for people living with HIV, as increased its users consistency in doctor visits and improved their health outcomes,…

A recent review of studies found that some people on PrEP engage in more risky sex. Even before PrEP hit the US market in 2012, there were fears that it would…

Despite the fact that PrEP is known to provide a high level of protection against HIV, aspects of its use remain controversial. The continued debates regarding the preventive tool pose…

You pretty much know the facts when it comes to HIV, right? Well, you might be falsely confident: A study of almost 2,000 people published in BMC Public Health found that almost half had…